Isabel Fabregat

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Venues

The Journal of pathology

Cancers

Cell death & disease

International journal of molecular sciences

Universitat de Barcelona

Universidad Autónoma de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat de Barcelona Sep 14 2007

Spain

Part-time associate professor :: Ciències Fisiològiques

Institut d'Investigacio Biomedica de Bellvitge Sep 01 2004

Spain

Senior Investigator :: TGF-beta & Cancer group. Oncobell Program.

Education History

Universidad Autónoma de Madrid Jul 01 1980 - Sep 30 1983

Spain

PHD :: Biochemistry and Molecular Biology

Publications

Ester Gonzalez-Sanchez, Javier Vaquero, Daniel Caballero-Diaz, Jan Grzelak, Noel P Fusté, Esther Bertran, Josep Amengual, Juan Garcia-Saez, Beatriz Martín-Mur, Marta Gut, Anna Esteve-Codina, Ania Alay, Cedric Coulouarn, Silvia Calero-Perez, Pilar Valdecantos, Angela M Valverde, Aránzazu Sánchez, Blanca Herrera, Isabel Fabregat
The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche. The Journal of pathology 263 (4-5) (2024)
Ester Gonzalez-Sanchez, Javier Vaquero, Daniel Caballero-Diaz, Jan Grzelak, Noel P Fusté, Esther Bertran, Josep Amengual, Juan Garcia-Saez, Beatriz Martín-Mur, Marta Gut, Anna Esteve-Codina, Ania Alay, Cedric Coulouarn, Silvia Calero-Perez, Pilar Valdecantos, Angela M Valverde, Aránzazu Sánchez, Blanca Herrera, Isabel Fabregat
The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche. The Journal of pathology 263 (4-5) (2024)
Josep Amengual, Ania Alay, Javier Vaquero, Ester Gonzalez-Sanchez, Esther Bertran, Aránzazu Sánchez, Blanca Herrera, Kathleen Meyer, Mate Maus, Manuel Serrano, María Luz Martínez-Chantar, Isabel Fabregat
Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression. Cell death & disease 15 (9) (2024)
Raquel Ramos, Antònia Vinyals, Rafael Campos-Martin, Eduard Cabré, Joan Josep Bech, Javier Vaquero, Ester Gonzalez-Sanchez, Esther Bertran, Josep Ramon Ferreres, Daniel Lorenzo, Carolina G De La Torre, Isabel Fabregat, Josep Maria Caminal, Àngels Fabra
New Insights into the Exosome-Induced Migration of Uveal Melanoma Cells and the Pre-Metastatic Niche Formation in the Liver. Cancers 16 (17) (2024)
Ester Gonzalez-Sanchez, Javier Vaquero, Daniel Caballero-Diaz, Jan Grzelak, Noel P Fusté, Esther Bertran, Josep Amengual, Juan Garcia-Saez, Beatriz Martín-Mur, Marta Gut, Anna Esteve-Codina, Ania Alay, Cedric Coulouarn, Silvia Calero-Perez, Pilar Valdecantos, Angela M Valverde, Aránzazu Sánchez, Blanca Herrera, Isabel Fabregat
The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche. The Journal of pathology (2024)
Francesco Dituri, Gianluigi Gigante, Rosanna Scialpi, Serena Mancarella, Isabel Fabregat, Gianluigi Giannelli
Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma. Cancers 14 (8) (2022)
Nerea Lazcanoiturburu, Juan García-Sáez, Carlos González-Corralejo, Cesáreo Roncero, Julián Sanz, Carlos Martín-Rodriguez, M Pilar Valdecantos, Adoración Martínez-Palacián, Laura Almalé, Paloma Bragado, Silvia Calero-Pérez, Almudena Fernández, María García-Bravo, Carmen Guerra, Lluís Montoliu, José Carlos Segovia, Ángela M Valverde, Isabel Fabregat, Blanca Herrera, Aránzazu Sánchez
Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response. The Journal of pathology 258 (3) (2022)
Irene Peñuelas-Haro, Rut Espinosa-Sotelo, Eva Crosas-Molist, Macarena Herranz-Itúrbide, Daniel Caballero-Díaz, Ania Alay, Xavier Solé, Emilio Ramos, Teresa Serrano, María Luz Martínez-Chantar, Ulla G Knaus, José M Cuezva, Antonio Zorzano, Esther Bertran, Isabel Fabregat
The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression. Hepatology (Baltimore, Md.) (2022)
Serena Mancarella, Grazia Serino, Sergio Coletta, Raffaele Armentano, Francesco Dituri, Francesco Ardito, Andrea Ruzzenente, Isabel Fabregat, Gianluigi Giannelli
The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma Progression. International journal of molecular sciences 23 (8) (2022)
Aida Sabaté-Llobera, Judit Mestres-Martí, Gabriel Reynés-Llompart, Laura Lladó, Kristel Mils, Teresa Serrano, Montserrat Cortés-Romera, Esther Bertran, Isabel Fabregat, Emilio Ramos
2-[18F]FDG PET/CT as a Predictor of Microvascular Invasion and High Histological Grade in Patients with Hepatocellular Carcinoma. Cancers 13 (11) (2021)
Macarena Herranz-Itúrbide, Irene Peñuelas-Haro, Rut Espinosa-Sotelo, Esther Bertran, Isabel Fabregat
The TGF-β/NADPH Oxidases Axis in the Regulation of Liver Cell Biology in Health and Disease. Cells 10 (9) (2021)
Francesco Dituri, Serena Mancarella, Grazia Serino, Nada Chaoul, Luigi Giovanni Lupo, Erica Villa, Isabel Fabregat, Gianluigi Giannelli
Direct and Indirect Effect of TGFβ on Treg Transendothelial Recruitment in HCC Tissue Microenvironment. International journal of molecular sciences 22 (21) (2021)
Ester Gonzalez-Sanchez, Javier Vaquero, Maite G Férnandez-Barrena, Juan Jose Lasarte, Matias A Avila, Pablo Sarobe, Maria Reig, Mariona Calvo, Isabel Fabregat
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma? Cancers 13 (13) (2021)
Pablo Fernandez-Tussy, Rubén Rodríguez-Agudo, David Fernández-Ramos, Lucía Barbier-Torres, Imanol Zubiete-Franco, Sergio López de Davalillo, Elisa Herraez, Naroa Goikoetxea-Usandizaga, Sofia Lachiondo-Ortega, Jorge Simón, Fernando Lopitz-Otsoa, Virginia Gutiérrez-de Juan, Misti V McCain, Maria J Perugorria, Jon Mabe, Nicolás Navasa, Cecília Maria Pereira Rodrigues, Isabel Fabregat, Loreto Boix, Victor Sapena, Juan Anguita, Shelly C Lu, Jose M Mato, Jesus M Banales, Erica Villa, Helen L Reeves, Jordi Bruix, Maria Reig, Jose J G Marin, Teresa C Delgado, María Luz Martínez-Chantar
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity. Cell death & disease 12 (6) (2021)
Jitka Soukupova, Andrea Malfettone, Esther Bertran, Maria Isabel Hernández-Alvarez, Irene Peñuelas-Haro, Francesco Dituri, Gianluigi Giannelli, Antonio Zorzano, Isabel Fabregat
Epithelial-Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism. International journal of molecular sciences 22 (11) (2021)
Bhavna Rani, Andrea Malfettone, Francesco Dituri, Jitka Soukupova, Luigi Lupo, Serena Mancarella, Isabel Fabregat, Gianluigi Giannelli
Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression. Cell death & disease 9 (3) (2018)
Jitka Soukupova, Andrea Malfettone, Petra Hyroššová, María-Isabel Hernández-Alvarez, Irene Peñuelas-Haro, Esther Bertran, Alexandra Junza, Jordi Capellades, Gianluigi Giannelli, Óscar Yanes, Antonio Zorzano, José Carlos Perales, Isabel Fabregat
Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism. Scientific reports 7 (1) (2017)
Claudia Bellomo, Laia Caja, Isabel Fabregat, Wolfgang Mikulits, Dimitris Kardassis, Carl-Henrik Heldin, Aristidis Moustakas
Snail mediates crosstalk between TGFβ and LXRα in hepatocellular carcinoma. Cell death and differentiation 25 (5) (2017)
Joaquim Moreno-Càceres, Daniel Caballero-Díaz, Zeribe Chike Nwosu, Christoph Meyer, Judit López-Luque, Andrea Malfettone, Raquel Lastra, Teresa Serrano, Emilio Ramos, Steven Dooley, Isabel Fabregat
The level of caveolin-1 expression determines response to TGF-β as a tumour suppressor in hepatocellular carcinoma cells. Cell death & disease 8 (10) (2017)

Isabel Fabregat.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Isabel Fabregat